Minson AG, Hamad N, Cheah CY, Tam CS, et al. CAR T-cells and Time-Limited Ibrutinib as Treatment for Relapsed/Refractory Mantle Cell Lymphoma: Phase II TARMAC Study. Blood 2023 Oct 26:blood.2023021306. doi: 10.1182/blood.2023021306.
PMID: 37883795